This is in agreement with a large body of evidence indicating metabolic inflexibility in response to different metabolic and physiological challenges (e.g., insulin stimulation, varying dietary compositions, exercise) in obesity, insulin resistance, metabolic syndrome, and type 2 diabetes (2–4, 27, 33–37). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.